# Progress Note 05 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Swami Vivekananda (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI032-SYN-TD
- Date: 1898-10-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anjali Thornbury-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient, with bronchodilator treatment, chest X-ray, ECG and reassessment in clinic

## Chief complaint

Attacks of breathlessness and wheeze, the worst last night, two days after returning from the mountains. **S**

## History of present illness

Swami Vivekananda returned two days ago from seven months of travel in the mountains. He was well in the dry, cool hills. For about three weeks, since coming down to the damp plains, he has had attacks of wheeze, cough and tightness lasting hours, mostly at night, and last night he sat up for most of the night feeling that he was suffocating. Smoke from the kitchen fires and incense make it worse. He has never had asthma diagnosed and has no inhaler. He has no fever, chest pain, ankle swelling or orthopnea between attacks, and no green sputum. He has taken metformin 1872 mg, losartan and atorvastatin throughout his travels; his fasting readings were 110 to 135 mg/dL, and 196 mg/dL this morning after a sleepless night. **S**

| Element | Detail |
|---|---|
| Onset | Three weeks, since coming down to the plains; worst last night |
| Severity | Sat up most of the night; speaks in sentences today; peak flow 330 L/min |
| Context | Type 2 diabetes on metformin; no previous asthma diagnosis or inhaler |
| Associated signs and symptoms | Night cough; no fever, chest pain, edema or purulent sputum |
| Glucose | Fasting 110 to 135 mg/dL while travelling; 196 mg/dL this morning |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Exhausted after a sleepless night; no fever |
| Respiratory | Positive | Wheeze, cough, chest tightness and breathlessness at night |
| Cardiovascular | Negative | No chest pain, palpitations at rest, orthopnea between attacks or ankle swelling |
| Ears, nose, mouth, and throat | Negative | No cold or sore throat |

4 systems reviewed. **S**

## Current medications

- Metformin extended-release 500 mg tablets: four tablets (1872 mg) with the evening meal; on fast days with the meal that ends the fast; hold if vomiting, diarrhea or unable to drink **S**
- Losartan 25 mg oral tablet, one tablet daily **S**
- Atorvastatin 10 mg oral tablet, one tablet daily **S**
- Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days **S**
- Budesonide-formoterol 160/4.5 mcg inhaler with a spacer, one inhalation as needed for wheeze or breathlessness, no more than 12 inhalations a day, until lung function testing **S**

## Allergies

- No known allergy **S**

## Objective

BP 132/82 mmHg; pulse 108 bpm; respirations 24/min; temperature 36.9 °C; oxygen saturation 94% on room air; weight 74.6 kg; BMI 25.2 kg/m². All vital signs are synthetic.

Peak expiratory flow: 330 L/min (low). All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Tired, sitting upright, speaking in full sentences; mild use of the neck muscles |
| Vital signs | Pulse 108, respiratory rate 24, oxygen saturation 94 percent on room air, temperature 36.9 °C; peak flow 330 L/min (56 percent of predicted) |
| Respiratory | Widespread expiratory wheeze with fair air entry; no crackles |
| Cardiovascular | Tachycardic, regular; jugular venous pressure not raised; no edema |
| Reassessment after one hour | After albuterol 4 puffs by spacer three times over an hour: peak flow 410 L/min (69 percent, a rise of 24 percent), oxygen saturation 96 percent, pulse 98, wheeze much reduced |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Attacks of wheeze and breathlessness: probable asthma, moderate attack** (R06.2). A moderate attack of what is most likely asthma, beginning in adult life and brought on by the damp plains and smoke: peak flow 56 percent of predicted rising 24 percent with albuterol, oxygen saturation 94 percent, speaking in sentences. Heart failure and pneumonia are unlikely: no fever, edema or orthopnea, a normal jugular venous pressure, and a chest X-ray without edema or consolidation; the ECG shows only sinus tachycardia. Rapid influenza and COVID-19 tests are negative. Safe to go home with treatment. **S**
   - Prednisone 40 mg each morning for five days.
   - Budesonide-formoterol one inhalation as needed, up to 12 a day, with a spacer, until spirometry next week.
   - Emergency care or 911 for breathlessness at rest, inability to speak in sentences, blue lips or no relief from the inhaler.
   - Avoid kitchen smoke and incense in his room for now.
   - Review in one week with spirometry before and after bronchodilator and FeNO.
2. **Type 2 diabetes** (E11.65). Prednisone will raise his glucose, mainly in the afternoon and evening, for the five days and a day or two after. He is not fasting this week. **S**
   - Check glucose before breakfast and before the evening meal while on prednisone.
   - Continue metformin; call if two readings are above 300 mg/dL or he cannot eat or drink, so that short-term insulin can be considered.
   - No religious fast while he is on prednisone and unwell, as he agreed.

## Medication changes

- Started: Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days **S**
- Started: Budesonide-formoterol 160/4.5 mcg inhaler with a spacer, one inhalation as needed for wheeze or breathlessness, no more than 12 inhalations a day, until lung function testing **S**

## Guideline basis

- 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020), National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)

## Follow-up

- Review in one week with spirometry and FeNO; telephone call from the nurse in two days about breathing and glucose. **S**
- Next scheduled visit 1898-10-27: review after seven months away and a week after an asthma attack: A1c, kidneys, lipids, spirometry with bronchodilator response and FeNO; asthma and diabetic kidney disease confirmed; empagliflozin and maintenance-and-reliever inhaler; fasting plan for the coming festival. **S**
